BOSTON--(BUSINESS WIRE)--
Orthofix International N.V. (NASDAQ: OFIX) (the Company) announced today
that Thomas J. Kester has resigned, effective immediately, from the
Company's Board of Directors. Mr. Kester has been an independent
Director of Orthofix since August of 2004. He served as a member of the
Audit Committee and Chairman of the Compensation Committee. His
resignation is not because of a disagreement with the Company on any
matter relating to the Company's operations, policies or practices.
Jim Gero, Chairman of the Board, stated, "We wish to publicly thank Tom
Kester for his contribution to the Company during the last six years.
Tom's experience and contributions have benefited the Company and we
appreciate the time he has devoted to Orthofix, and wish him well in his
future endeavors."
About Orthofix International, N.V.
Orthofix International, N.V. is a global medical device company offering
a broad line of minimally invasive surgical and non-surgical products
for the spine, orthopedic, and sports medicine market sectors, that
address the lifelong bone-and-joint health needs of patients of all ages
- helping them achieve a more active and mobile lifestyle. Orthofix's
products are widely distributed around the world to orthopedic surgeons
and patients via Orthofix's sales representatives and its subsidiaries,
and via collaborations with other leading orthopedic product companies.
In addition, Orthofix is collaborating and investing in R&D activities
with leading medical institutions such as the Musculoskeletal Transplant
Foundation, the Orthopedic Research and Education Foundation, The
University of Medicine and Dentistry of New Jersey and the National
Osteoporosis Institute. For more information about Orthofix, please
visit www.orthofix.com.
Orthofix International N.V.
Dan Yarbrough, 617-912-2903
Vice
President of Investor Relations
danyarbrough@orthofix.com
Source: Orthofix International N.V.
News Provided by Acquire Media